Data as of Apr 16
| +0.59 / +7.16%|
The 2 analysts offering 12-month price forecasts for Ocera Therapeutics Inc have a median target of 22.50, with a high estimate of 26.00 and a low estimate of 19.00. The median estimate represents a +154.81% increase from the last price of 8.83.
The current consensus among 3 polled investment analysts is to Buy stock in Ocera Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.